The research, led by Shola Hezekiah Awojide and colleagues at Osun State University, began with a familiar problem in pharmacology. Essential oils such as clove oil are packed with biologically active compounds, but they are notoriously difficult to deliver in the body. They dissolve poorly in water and evaporate readily, which limits how much of the active chemistry ever reaches its target. Rather than discarding the oil’s limitations, the team exploited its strengths. They extracted the essential oil from clove buds by steam distillation using a Clevenger apparatus, heating ground buds for five hours to release their fragrant cargo, and then used that oil as both the factory and the packaging for silver nanoparticles.

The chemistry at the heart of the process is elegantly simple. Silver nitrate dissolves in water to release positively charged silver ions. Eugenol, the phenolic compound that makes up roughly 80 percent of clove oil, donates electrons from its hydroxyl group, reducing those ions to neutral metallic silver atoms. The atoms cluster into stable nuclei, grow into nanoparticles, and are then capped and stabilized by eugenol and other oil constituents that anchor to the particle surface through oxygen-containing functional groups and pi-electron interactions. In effect, the same molecule that gives cloves their aroma acts as reducing agent, growth regulator, and protective coating all at once, eliminating the toxic solvents and reducing chemicals that conventional nanoparticle synthesis typically requires.

Confirmation that the transformation had worked came within ten minutes, when the reaction mixture shifted from light yellow to grey. Ultraviolet-visible spectroscopy recorded a maximum absorption at 421 nanometers, the signature of localized surface plasmon resonance, a phenomenon that occurs when conduction electrons on metallic nanoparticles oscillate collectively under light. Fourier transform infrared spectroscopy then revealed peaks at 3433 and 1639 per centimeter, corresponding to hydroxyl and alkenyl carbon-carbon stretching vibrations, with a telltale shift of the broad hydroxyl band from 3445 to 3433 per centimeter. That shift indicated that the hydroxyl, phenolic, and methoxyl groups of eugenol had participated in reducing the silver ions and remained attached to the finished particles, capping them in a biologically active shell.

X-ray diffraction confirmed that the particles were crystalline silver with a face-centered cubic structure, showing characteristic diffraction peaks at 2-theta values of 38.67, 44.55, and 64.74 degrees, matching the 111, 200, and 220 crystallographic planes. Using the Debye-Scherrer equation, the team calculated an average crystallite size of 30.58 nanometers. But the electron microscopes told an even more striking story. Scanning electron microscopy measured an average particle diameter of 6.0 nanometers, while transmission electron microscopy placed it at 6.63 nanometers, with a narrow size distribution between 2.72 and 15.30 nanometers. The particles were overwhelmingly spherical, a morphology the researchers attribute to eugenol’s stabilizing grip on particle growth. Energy dispersive X-ray spectroscopy confirmed silver as the dominant element, with traces of carbon, magnesium, potassium, and silicon attributable to organic residues and instrumental components.

That size matters enormously. Particles around six nanometers carry an exceptionally high surface-area-to-volume ratio, providing abundant reactive sites for interaction with biological molecules. Previous work has suggested that silver nanoparticles in the five to ten nanometer range show particularly strong anti-inflammatory activity, while spherical particles tend to outperform other shapes in antidiabetic assays. The Nigerian team’s particles landed squarely in the sweet spot on both counts, and the phytochemical coating may add a synergistic layer of activity on top of the silver core itself.

The biological testing results were remarkable. In the DPPH free-radical scavenging assay, the nanoparticles recorded a half-maximal inhibitory concentration of 235.39 micrograms per milliliter, beating ascorbic acid at 315.78. In the ABTS assay, the particles achieved 82 percent inhibition at 500 micrograms per milliliter, with an IC50 of 215.50 micrograms per milliliter against 350.50 for the vitamin C standard. The nanoparticles also inhibited lipid peroxidation more effectively than gallic acid, with an IC50 of 198.24 versus 229.82 micrograms per milliliter, and scavenged nitric oxide radicals better than rutin, at 197.81 versus 274.06 micrograms per milliliter. In every antioxidant test, the clove-derived particles outperformed the established benchmark compound.

The antidiabetic results may prove the most consequential. Inhibiting the digestive enzymes alpha-amylase and alpha-glucosidase is a proven strategy for controlling post-meal blood sugar spikes in diabetes, and the nanoparticles beat the clinical drug acarbose in both assays. Against alpha-amylase, the particles showed an IC50 of 155.31 micrograms per milliliter compared with 224.92 for acarbose. Against alpha-glucosidase, the nanoparticles inhibited more than 90 percent of enzyme activity at 500 micrograms per milliliter, compared with roughly 70 percent for acarbose, and recorded an IC50 of 154.10 micrograms per milliliter against 252.86 for the drug. The researchers propose that the particles’ vast surface area allows them to bind directly to the enzymes’ active sites, blocking substrate access, while non-covalent interactions with the protein surface further impede carbohydrate breakdown. In the anti-inflammatory membrane stabilization assay, which measures the ability to protect red blood cells from rupture under stress, the nanoparticles achieved 80 percent inhibition at the highest concentration, with an IC50 of 226.62 micrograms per milliliter, comfortably ahead of the standard drug diclofenac sodium at 293.77.

The authors caution that these are in vitro results, and important questions remain unanswered. The study did not include microbial profiling, cytotoxicity testing, or animal validation, all of which are essential before any therapeutic claim can be made. Silver nanoparticles can behave very differently inside living organisms than in a test tube, and safety data will determine whether these particles ever approach the clinic. The team recommends that future work focus on comprehensive antimicrobial studies, cytotoxicity assays, and in vivo investigations, and suggests exploring the particles as components of drug delivery systems, wound healing materials, and pharmaceutical formulations.

Even with those caveats, the study offers a compelling demonstration of green chemistry’s potential. A spice that has flavored food and treated ailments for millennia has yielded a nanomaterial that, in laboratory conditions, outperformed vitamin C, gallic acid, rutin, acarbose, and diclofenac sodium across three categories of therapeutic activity. The eugenol molecule that gives cloves their bite turns out to be a masterful nanoscale engineer, reducing, shaping, and stabilizing silver particles at room temperature without a single hazardous reagent. If subsequent safety and efficacy studies hold up, the humble clove may find itself at the center of a new generation of eco-friendly nanomedicines.

Subject of Research: Green synthesis of silver nanoparticles from clove essential oil and their antioxidant, antidiabetic, and anti-inflammatory activities

Article Title: Green synthesis, characterization, determination of antioxidant, antidiabetic, and anti-inflammatory activities of silver nanoparticles from Syzygium aromaticum essential oil

Article References: Green synthesis, characterization, determination of antioxidant, antidiabetic, and anti-inflammatory activities of silver nanoparticles from Syzygium aromaticum essential oil. (n.d.). https://doi.org/10.1007/s44371-026-00976-z

Image Credits: AI Generated

DOI: 10.1007/s44371-026-00976-z

Keywords: silver nanoparticles, green synthesis, Syzygium aromaticum, clove essential oil, eugenol, antioxidant, antidiabetic, anti-inflammatory, nanomedicine, X-ray diffraction, alpha-glucosidase inhibition, phytochemicals